Exoskeleton Rehabilitation Global Market Report 2025

The exoskeleton rehabilitation market size has grown rapidly in recent years. It will grow from $1.1 billion in 2024 to $1.3 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. Growth in the historic period can be attributed to the rising incidence of age-related mobility impairments, increased demand for intensive post-stroke physical rehabilitation, growing prevalence of workplace injuries requiring structured recovery programs, a surge in military veterans needing long-term mobility support, expanding insurance coverage for advanced rehabilitation therapies, and a heightened emphasis on early mobility interventions in hospital settings.

The exoskeleton rehabilitation market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. Growth in the forecast period can be linked to increasing investment in specialized rehabilitation centers, a stronger focus on long-term care for chronic mobility disorders, rising government funding for physical medicine and rehabilitation services, growing demand for sports injury rehabilitation, and greater adoption of integrated physical therapy pathways in healthcare facilities. Major trends expected during the forecast period include technological advancements in lightweight wearable frameworks, progress in intelligent motion-assistance control systems, innovations in patient-specific digital rehabilitation platforms, developments in sensor-embedded mobility training systems, and advancements in data-driven rehabilitation monitoring tools.

The increasing incidence of disabilities is expected to drive the growth of the exoskeleton rehabilitation market going forward. Disabilities refer to long-term physical, sensory, or cognitive impairments that limit an individual’s ability to carry out daily activities. The rising incidence of disabilities is largely driven by neurological disorders, as improved survival rates following strokes and injuries often result in lasting impairments. Exoskeleton rehabilitation assists individuals with disabilities by offering wearable robotic support, making it suitable for those with restricted mobility. It lessens physical strain by enabling guided movement and repetitive therapy, enhancing functional recovery and independence. For example, in July 2025, Eurostat, a Luxembourg-based statistical office of the European Union (EU), reported that in 2024, 23.9% of people aged 16 or older in the EU experienced a disability or activity limitation. Therefore, the rising incidence of disabilities is contributing to the expansion of the exoskeleton rehabilitation market.

Major companies in the exoskeleton rehabilitation market are focusing on developing advanced products, such as customizable-speed exoskeleton systems, to enhance mobility and therapy outcomes. Customizable-speed exoskeleton systems refer to rehabilitation exoskeletons that allow therapists or users to adjust walking or movement speeds to meet individual therapy requirements and patient abilities. For example, in April 2025, Lifeward Ltd., an Israel-based medical device company, introduced the ReWalk 7 Personal Exoskeleton, a customizable-speed exoskeleton system. It is a wearable robotic exoskeleton that provides powered hip and knee movement, allowing individuals with paraplegia to stand, walk, and climb stairs. It features improved stability elements and a more intuitive user interface for initiating movement, enabling smoother transitions between daily activities with greater confidence and reduced physical strain.

In June 2025, Bioness Medical Inc., a US-based rehabilitation technology company, acquired Harmonic Bionics Inc. for an undisclosed amount. This acquisition allows Bioness Medical to strengthen its rehabilitation robotics portfolio by integrating Harmonic Bionics’ upper-extremity exoskeleton technology and expertise. Harmonic Bionics Inc. is a US-based rehabilitation robotics company specializing in upper-extremity exoskeleton solutions.

Major companies operating in the exoskeleton rehabilitation market are Ottobock SE and Co KGaA, Fourier Intelligence, DIH Holding US Inc., Cyberdyne Inc., Wandercraft SAS, Myomo Inc., Ekso Bionics Holdings Inc., Tyromotion GmbH, Lifeward Inc., Able Human Motion SL, Bioservo Technologies AB, ExoAtlet Global SA, Bama Teknoloji, Focal Meditech BV, B Temia Inc., Bionik Laboratories Corp, Gogoa Mobility Robots SL, Rex Bionics Ltd., Wearable Robotics Srl, Bionic Yantra Private Limited

North America was the largest region in the exoskeleton rehabilitation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in exoskeleton rehabilitation report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the exoskeleton rehabilitation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The exoskeleton rehabilitation market research report is one of a series of new reports that provides exoskeleton rehabilitation market statistics, including the exoskeleton rehabilitation industry global market size, regional shares, competitors with the exoskeleton rehabilitation market share, detailed exoskeleton rehabilitation market segments, market trends, and opportunities, and any further data you may need to thrive in the exoskeleton rehabilitation industry. This exoskeleton rehabilitation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Exoskeleton rehabilitation is a therapeutic approach that utilizes wearable robotic devices to support or enhance a person’s limb movements during recovery from injuries or neurological conditions. These devices guide and assist natural movement patterns in a controlled manner, helping retrain muscles and nerves through repeated, precise motions. This method promotes improved mobility, faster functional recovery, and increased independence for individuals with conditions such as stroke or spinal cord injury.

The main product types of exoskeleton rehabilitation systems include lower limb exoskeletons, upper limb exoskeletons, and full-body exoskeletons. Lower limb exoskeletons are wearable robotic devices designed to support, enhance, or restore mobility in the hips, legs, and lower body during rehabilitation or everyday movement. These solutions are available in both mobile and stationary formats and utilize powered or passive technologies. They are used for conditions such as neurological disorders, orthopedic disorders, spinal cord injuries, stroke, and others, and serve various end users including hospitals and clinics, rehabilitation centers, home care settings, and additional care environments.

The exoskeleton rehabilitation market consists of revenues earned by entities by providing services such as robotic-assisted gait training, mobility restoration therapy, strength and balance training, patient assessment and monitoring, and maintenance and support of rehabilitation exoskeleton systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The exoskeleton rehabilitation market also includes sales of wearable robotic exoskeletons, powered gait-assist devices, sensor-integrated mobility systems, pediatric rehabilitation exoskeletons, hip-knee-ankle exoskeleton systems, and related control units and accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.